BRAF and melanoma: We recently provided evidence that panicein A hydroquinone not only increased the effect of classical chemotherapeutic treatments such as doxorubicin and cisplatin but also enhanced the effect of the BRAF inhibitor vemurafenib against BRAF mutated melanoma cells in vitro and in vivo [12].